Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...

Bausch + Lomb Corporation BLCO on Thursday said it will discontinue development of BL1107 as a topical treatment for glaucoma ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

The agency says pairing drug sponsors with research institutions could cut development timelines by 6 to 12 months ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

PROTACs have helped redefine what may be possible in drug discovery. By harnessing the ubiquitin-proteasome system to ...

While Evommune is terminating development of the oral drug in CSU, trials in AD and migraine prophylaxis will continue.

The demise of the two programmes still leaves Roche with one Huntington's candidate, the gene therapy RG6662, which is in a ...